+20.1%
GSK vs SHAK
-34.9%
+55.0%
-19.3%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | SHAK | Excess | Alpha |
|---|---|---|---|---|
| 1D | 0.0% | +3.2% | -3.1% | -0.2% |
| 7D | -3.5% | -8.3% | +4.8% | -3.0% |
| 30D | -3.4% | -12.6% | +9.2% | -2.7% |
| 3M | -8.1% | +9.1% | -17.2% | -8.9% |
| 6M | -11.1% | -31.2% | +20.1% | -9.8% |
| YTD | +0.7% | -21.6% | +22.3% | +1.6% |
| 1Y | +20.1% | -38.8% | +58.9% | +18.7% |
| All | +20.1% | -34.9% | +55.0% | +18.7% |
Cumulative growth
Daily Returns
Daily percentage return beside SHAK.
Daily Out/Under-Performance
Portfolio return minus SHAK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × SHAK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded SHAK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling